New culprit in amyloid beta buildup, neurodegeneration

Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain. This triggers a reaction that damages blood vessels and causes neurodegeneration.

New strategy attacks treatment-resistant lymphomas

Weill Cornell Medicine and NewYork-Presbyterian investigators discover a surprising mechanism that makes some cancers resistant to treatment.

Cornell Bowers CIS researchers bring home awards from CSCW

Research on the role of hope in community work, online support groups and moderating online communities received awards at the 2023 Conference on Computer-Supported Cooperative Work And Social Computing.

Around Cornell

Mobile units increase odds of averting stroke

Receiving a clot-busting drug in an ambulance-based mobile stroke unit increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, a new study shows.

Gut fungi amplify inflammation in severe COVID-19

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Estrogen therapy’s effect on Alzheimer’s needs more study

Research findings suggest that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken estrogen.

Uptick in pediatric mental health ER visits persists through pandemic

Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Large-scale study reveals new genetic details of diabetes

In experiments of unprecedented scale, researchers at Weill Cornell Medicine and the NIH have advanced efforts to better understand and ultimately treat this common metabolic disease.

New student residence will expand Weill Cornell’s scope

Weill Cornell Medicine is constructing a modern student residence that, when it opens in 2025, will nearly double the existing student residential living space.